Abstract
BackgroundAchieving sustained remission is nowadays a realistic treatment goal in patients with rheumatoid arthritis (RA). However, the effect of methotrexate (MTX) on sustained remission in treatment with adalimumab and etanercept...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
